Major trials

KCCQ-CSS (Kansas City Cardiomyopathy Questionnaire — Clinical Summary Score)

The Phase 3 trials that won approval, and the outcome studies that came afterward on cardiovascular, kidney and sleep-apnea endpoints.

Definition

The Kansas City Cardiomyopathy Questionnaire clinical summary score, a validated patient-reported measure of heart-failure symptoms and physical limitation. Scored 0–100, higher is better, and five points is the threshold for clinically meaningful. STEP-HFpEF reported 7.8 points on semaglutide against 2.6 on placebo — the primary endpoint behind the 2024 EMA and FDA filings in HFpEF with obesity.

Top GLP-1 cardiovascular studies

GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature. Not one of them is an AI-generated summary.

Other terms under Major trials

Where the evidence lives